Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment

黑素皮质素 黑素皮质素4受体 丙种皮质醇 黑素皮质激素受体 瘦素 黑皮素 内分泌学 内科学 小鼠苗条素受体 受体 生物 肥胖 激素 医学
作者
Peter Kühnen,Heiko Krude,Heike Biebermann
出处
期刊:Trends in Molecular Medicine [Elsevier]
卷期号:25 (2): 136-148 被引量:120
标识
DOI:10.1016/j.molmed.2018.12.002
摘要

The melanocortin-4 receptor (MC4R) plays an important role in body-weight regulation. Recent proof-of-concept studies have successfully investigated MC4R agonists as a treatment option for rare monogenic forms of obesity. MC4R-related non-Gs signalling is supposed to be a key element in the regulation of satiety, which provides evidence that more MC4R mutations are functionally relevant and contribute to the development of obesity than was previously thought. The evaluation of MC4R signalling pathways is of importance, as this receptor is a promising target for antiobesity drug development. The melanocortin-4 receptor (MC4R) – embedded in the leptin–melanocortin pathway – is activated by proopiomelanocortin (POMC)-derived neuropeptides such as α- and β-melanocyte-stimulating hormone (MSH) and plays an important role in hypothalamic body-weight regulation. Accordingly, MC4R is a potential drug target to combat obesity. Previous attempts to develop MC4R agonists failed due to ineffectiveness or severe adverse events. Recently, a new generation of MC4R ligands was developed. Specifically, setmelanotide was found to be effective by inducing biased signalling of the MC4R and thereby reducing feelings of hunger and leading to substantial weight loss in patients with POMC or leptin receptor deficiency. This new potential pharmacological treatment option could be beneficial for further groups of obese patients with defects in the leptin–melanocortin signalling pathway. The melanocortin-4 receptor (MC4R) – embedded in the leptin–melanocortin pathway – is activated by proopiomelanocortin (POMC)-derived neuropeptides such as α- and β-melanocyte-stimulating hormone (MSH) and plays an important role in hypothalamic body-weight regulation. Accordingly, MC4R is a potential drug target to combat obesity. Previous attempts to develop MC4R agonists failed due to ineffectiveness or severe adverse events. Recently, a new generation of MC4R ligands was developed. Specifically, setmelanotide was found to be effective by inducing biased signalling of the MC4R and thereby reducing feelings of hunger and leading to substantial weight loss in patients with POMC or leptin receptor deficiency. This new potential pharmacological treatment option could be beneficial for further groups of obese patients with defects in the leptin–melanocortin signalling pathway. a substance that is able to activate a receptor. a neuropeptide produced in the ARC that is an endogenous antagonist and inverse agonist of MC4R. a hypothalamic nucleus where POMC is expressed. surgical intervention to treat obesity. Strategies include gastric banding, Roux-en-Y gastric bypass, and sleeve gastrectomy. also known as functional selectivity; describes the signalling properties of a ligand differing from those of the endogenous ligand of the receptor. genetic variants are localised at different positions on the paternal and the maternal allele. concentration of a substance that is needed to achieve the half-maximal effect. pharmacological term for the maximal effect of a substance (e.g., a drug). the largest family of membrane spanning receptors, with a complex structure of seven transmembrane helices that are connected by three extracellular and three intracellular loops. The N terminus is extracellular and the C terminus is intracellular. GPCRs can couple to Gs, which activates adenylyl cyclase, to Gi, which inhibits adenylyl cyclase, to Gq proteins, which activate phospholipase C-β, and to G12/13, which activates RhoA. a condition of constantly increased feelings of hunger. the most important pathway in hypothalamic weight regulation, which integrates hormonals signals from the periphery to exert a centrally mediated reaction. a compound that can bind to a receptor. a hypothalamic nucleus where MC4R is expressed. a large precursor protein that is expressed in the pituitary, skin, and hypothalamus; processing by prohormone convertases results in melanocortins (α and β), ACTH, and β-endorphin.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源应助Vickie_T采纳,获得10
刚刚
搞怪代桃发布了新的文献求助10
1秒前
今后应助初七123采纳,获得10
1秒前
Alice完成签到,获得积分10
2秒前
缓慢珠发布了新的文献求助10
3秒前
zpf应助viyou采纳,获得10
3秒前
善学以致用应助AKACrown采纳,获得30
3秒前
4秒前
Tt发布了新的文献求助10
5秒前
脑袋里面没有脑子完成签到,获得积分10
6秒前
七里香完成签到 ,获得积分10
6秒前
7秒前
tianzml0应助cc采纳,获得10
7秒前
爆米花应助明年今日采纳,获得10
8秒前
抱住仙人球应助kento采纳,获得100
8秒前
8秒前
8秒前
笨笨猪完成签到,获得积分10
9秒前
NexusExplorer应助经竺采纳,获得10
9秒前
9秒前
顺心醉蝶完成签到,获得积分10
10秒前
10秒前
10秒前
dhlswpu完成签到,获得积分10
11秒前
管恩杰发布了新的文献求助10
12秒前
情怀应助健康的雁凡采纳,获得10
12秒前
13秒前
董咚咚完成签到,获得积分10
13秒前
甜甜凡蕾完成签到,获得积分10
13秒前
paper发布了新的文献求助10
14秒前
1234完成签到,获得积分10
14秒前
初七123发布了新的文献求助10
14秒前
撒大苏打发布了新的文献求助10
15秒前
科研小趴菜蔚酱关注了科研通微信公众号
15秒前
jjh完成签到,获得积分10
15秒前
美好斓发布了新的文献求助30
16秒前
17秒前
17秒前
Yuan发布了新的文献求助10
17秒前
我是老大应助海棠采纳,获得30
18秒前
高分求助中
Sustainability in ’Tides Chemistry 2000
Sustainability in ’Tides Chemistry 1500
Studien zur Ideengeschichte der Gesetzgebung 1000
The ACS Guide to Scholarly Communication 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Handbook of the Mammals of the World – Volume 3: Primates 805
Ethnicities: Media, Health, and Coping 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3071772
求助须知:如何正确求助?哪些是违规求助? 2725690
关于积分的说明 7490802
捐赠科研通 2373068
什么是DOI,文献DOI怎么找? 1258410
科研通“疑难数据库(出版商)”最低求助积分说明 610277
版权声明 596938